Dekel Pharmaceuticals
Compositions for Inflammatory Disorders
Health Tech & Life Sciences
Acquired (Inactive) by SciSparc on Oct 2014 - closed due to acquisition
Company Overview
Snapshot
Founded in October 2008, Dekel Pharmaceuticals operates with 1–10 employees. The company was acquired by SciSparc in October 2014, marking a significant milestone in its corporate trajectory.
Business overview
Dekel Pharmaceuticals specializes in the development of compositions and methods for treating inflammatory disorders. The company's core technology focuses on creating solutions within the pharmaceutical sector, serving the broader healthcare and life sciences industries.
Log in to access full profile ›Company Intelligence Q&A
- What is Dekel Pharmaceuticals' primary focus?
- Dekel Pharmaceuticals develops compositions and methods for the treatment of inflammatory disorders.
- When was Dekel Pharmaceuticals founded?
- Dekel Pharmaceuticals was founded in October 2008.
- What is the current status of Dekel Pharmaceuticals?
- Dekel Pharmaceuticals was acquired by SciSparc in October 2014 and is currently inactive.
- In which sector does Dekel Pharmaceuticals primarily operate?
- Dekel Pharmaceuticals operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What business model does Dekel Pharmaceuticals utilize?
- Dekel Pharmaceuticals operates on a B2B business model.